Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

May 4, 2017May 4, 2017

T-Follicular Helper Cells Critical in Protecting Against Pneumococcal Pneumonia, Australian Study Shows

T-follicular helper cells generate antibodies that prevent people from getting pneumococcal pneumonia, according to a Australian study whose findings offer important insights on why some people are more vulnerable to the ... Read more

April 25, 2017

ResApp Extends Study Testing Effectiveness of New Software in Kids with Lung Diseases

ResApp Health will extend a clinical trial evaluating its investigative software ResAppDx to 1,500 children with respiratory diseases. The trial is now expected to end in May. The clinical SMARTCOUGH-C trial (NCT02973282) ... Read more

April 4, 2017April 4, 2017

Bedside Lung Probe Aims to Diagnose Bacterial Infections Rapidly, Cutting Antibiotics Overuse

Scottish researchers are developing fluorescent imaging technology to diagnose pneumonia and other bacterial lung infections within 60 seconds, so patients can receive the right medication quickly. Scientists hope their Proteus lung probe ... Read more

March 16, 2017March 16, 2017

Lung Therapeutics Doses First Patient in Trial of LTI-01 for Empyema, Pleural Effusion

Lung Therapeutics has enrolled its first patient in a Phase 1 a/b clinical trial assessing LTI-01, a drug designed to treat pleural effusions, a severe complication of pneumonia. The study, taking place at ... Read more

February 28, 2017February 28, 2017

World Health Organization Releases List of Bacteria Most in Need of New Antibiotics

The World Health Organization (WHO) has released a list of 12 treatment-resistant bacteria that it says researchers urgently need to develop new antibiotics for. It drew up the list of priority pathogens, including some ... Read more

February 23, 2017February 23, 2017

Asthma Drugs Could Also Prevent Influenza Viral Pneumonia, Study Finds

Two therapies used to control and prevent asthma attacks and allergies might also protect people from a potentially deadly respiratory infection known as influenza viral pneumonia, a new study shows. The study, ... Read more

February 21, 2017February 21, 2017

Breakthrough Made in Fight Against Antiobiotic-resistant Superbug

Researchers have discovered why a killer superbug is becoming more resistant to antibiotics. The findings open new doors to the development of potential treatments to fight the lethal infection that causes pneumonia ... Read more

February 2, 2017February 2, 2017

Lung Ultrasound Can Help Diagnose Pneumonia Masked as Pulmonary Embolism

A lung ultrasound can detect patients who are at increased risk for pulmonary embolism better than the commonly used Wells score (a pulmonary embolism probability scoring). The technique can also ... Read more

January 31, 2017January 31, 2017

Pulmonary Center Director Wins $5.9M Grant to Further Study of Pneumonia

The director of the Pulmonary Center at Boston University’s School of Medicine has won an Outstanding Investigator Award to continue research into the biology of pneumonia. The seven-year, $5.9 million grant given Joseph P. Mizgerd by the National Heart, ... Read more

January 26, 2017January 26, 2017

Arsanis Doses First Patient in Phase 2 Trial of Therapy to Prevent S. Aureus Pneumonia

Arsanis has dosed the first patient in its Phase 2 clinical trial evaluating ASN100 as a prevention treatment for Staphylococcus aureus pneumonia in high-risk, mechanically ventilated patients. The randomized, double-blind, placebo-controlled clinical trial ... Read more